Table 2.
Summary of clinical variables of the study participants under follow-up
| Covariates | Attributes | Total | (%100) | Survival Status | |
|---|---|---|---|---|---|
| Death (%) | Censored (%) | ||||
| Cardiac disease |
Congenital Acquired |
230 93 |
71.21 28.79 |
24(10.43) 6(6.45) |
206(89.57) 87(93.55) |
| Chamber enlargements |
Yes No |
167 156 |
51.70 48.30 |
22(13.17) 8(5.13) |
145(86.83) 148(94.87) |
| Pulmonary hypertension |
Yes No |
52 271 |
16.10 83.90 |
14(26.92) 16(5.90) |
38(73.08) 255(94.10) |
| Corrective surgery |
Yes No |
47 276 |
14.55 85.45 |
3(6.38) 27(9.78) |
44(93.62) 249(90.22) |
| Nutritional status |
Under weight Healthy weight |
192 131 |
59.40 40.60 |
27(14.06) 3(2.29) |
165(85.94) 128(97.71) |
| ROSS/NYHA |
I II III IV |
110 125 62 26 |
34.05 38.69 19.19 8.05 |
2(1.82) 5(4.00) 9(14.52) 14(53.84) |
80(98.18) 140(96.00) 57(85.48) 16(46.15) |
| Heart failure |
No Mild Moderate to severe |
110 125 88 |
34.05 38.69 27.24 |
2(1.82) 5(4.00) 23(26.14) |
80(98.18) 140(96.00) 65(73.86) |
| Anemia |
Yes No |
114 209 |
35.29 64.71 |
14(12.28) 16(7.66) |
100(87.72) 193(92.34) |
| Pneumonia |
Yes No |
58 265 |
17.96 82.04 |
9(15.52) 21(7.92) |
49(84.48) 244(97.02) |
| Cardiomyopathy |
Yes No |
78 245 |
24.15 75.85 |
12(15.38) 18(7.35) |
66(84.62) 227(92.65) |